Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.63 |
| ▸ | MEN1 | O00255 | 3/20 | 0.63 |
| ▸ | MGLL | Q99685 | 1/20 | 0.58 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | SCN2A | Q99250 | 4/20 | 0.53 |
| ▸ | CA9 | Q16790 | 3/20 | 0.53 |
| ▸ | CA12 | O43570 | 2/20 | 0.53 |
| ▸ | CA1 | P00915 | 2/20 | 0.53 |
| ▸ | CA2 | P00918 | 2/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.51 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | DHODH | Q02127 | 1/20 | 0.49 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14600350 | 1.00 | KMT2A (0.63) | KMT2AMEN1MGLLNPSR1SCN2A | |
| SCHEMBL4649471 | 0.83 | KMT2A (0.78) | KMT2AMEN1SCN2ACA9CA12 | |
| SCHEMBL276940 | 0.82 | ESR1 (0.58) | KMT2AMEN1MGLLSCN2ACA9 | |
| SCHEMBL6789729 | 0.81 | KMT2A (0.62) | KMT2AMEN1NPSR1SCN2ACA9 | |
| SCHEMBL10907990 | 0.81 | KMT2A (0.54) | KMT2AMEN1NPSR1SCN2ACA9 | |
| SCHEMBL31211796 | 0.81 | PLA2G1B (0.56) | KMT2AMEN1NPSR1SCN2ACA9 | |
| SCHEMBL10453627 | 0.81 | KMT2A (0.63) | KMT2AMEN1NPSR1SCN2ACA9 | |
| SCHEMBL15295071 | 0.80 | KMT2A (0.53) | KMT2AMEN1NPSR1SCN2AGAA | |
| SCHEMBL29382180 | 0.80 | KMT2A (0.53) | KMT2AMEN1NPSR1SCN2AGAA | |
| SCHEMBL30472945 | 0.79 | ALDH1A1 (0.72) | KMT2AMEN1MGLLSCN2ACA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117868764-A | Method for improving productivity of oil-gas water well | 天津鸿鼎石油有限公司 | 2024-04-12 | — | — | CN | claimed |
| US-20260079778-A1 | INFORMATION PROCESSING APPARATUS, INFORMATION PROCESSING METHOD, AND NON-TRANSITORY COMPUTER-READABLE RECORDING MEDIUM | YOKOGAWA ELECTRIC CORP (JP) | 2026-03-19 | — | — | US | disclosed |
| EP-4711948-A1 | INFORMATION PROCESSING APPARATUS, INFORMATION PROCESSING METHOD, AND INFORMATION PROCESSING PROGRAM | Yokogawa Electric Corporation (JP) | 2026-03-18 | — | — | EP | disclosed |
| US-20260014248-A1 | MRNA FOR SARS-COV-2 S PROTEIN AND USE THEREOF | SHENZHEN SHENXIN BIOTECHNOLOGY CO LTD (CN) | 2026-01-15 | — | — | US | disclosed |
| US-12410164-B2 | Heterocyclic compounds and medical use thereof | FONDAZIONE TELETHON (IT) | 2025-09-09 | — | — | US | disclosed |
| EP-4560021-A1 | MRNA FOR SARS-COV-2 S PROTEIN AND USE THEREOF | Shenzhen Shenxin Biotechnology Co., Ltd. (CN) | 2025-05-28 | — | — | EP | disclosed |
| US-20250103037-A1 | CERTIFICATION SYSTEM, CERTIFICATION METHOD, AND COMPUTER-READABLE RECORDING MEDIUM | YOKOGAWA ELECTRIC CORPORATION (JP) | 2025-03-27 | — | — | US | disclosed |
| CN-118894902-B | Peptide derivatives, preparation method and application thereof | 云南苏理生物医药科技有限公司 | 2024-12-24 | — | — | CN | disclosed |
| CN-117868764-A | Method for improving productivity of oil-gas water well | 天津鸿鼎石油有限公司 | 2024-04-12 | — | — | CN | disclosed |
| WO-2024017253-A1 | MRNA FOR SARS-COV-2 S PROTEIN AND USE THEREOF | 深圳深信生物科技有限公司 | 2024-01-25 | — | — | WO | disclosed |
| CN-113293639-B | Modified crosslinked polyamide polyamine cylinder sticking agent applicable to high temperature and preparation method thereof | 济宁南天农科化工有限公司 | 2023-07-28 | — | — | CN | disclosed |
| CN-112708571-B | Recombinant saccharomycete for producing chondroitin sulfate with controllable molecular weight through fermentation and application thereof | 江南大学 | 2023-07-18 | — | — | CN | disclosed |
| CN-108733411-B | Method for setting up working instruction to be executed by MES/MOM system | 西门子股份公司 | 2023-07-04 | — | — | CN | disclosed |
| CN-114934056-A | mRNA vaccine based on novel mutant strain of coronavirus Onckrozen | 仁景(苏州)生物科技有限公司 | 2022-08-23 | — | — | CN | disclosed |
| US-20220187300-A1 | TUMOR CELL-DERIVED MICROVESICLES | THE HOSPITAL FOR SICK CHILDREN (CA) | 2022-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260079778-A1 | INFORMATION PROCESSING APPARATUS, INFORMATION PROCESSING METHOD, AND NON-TRANSITORY COMPUTER-READABLE RECORDING MEDIUM | TMCO1, DNMT3A, LSM8 | KMT2A 107/4885MEN1 882/4885MGLL 4683/4885 |
| US-12410164-B2 | Heterocyclic compounds and medical use thereof | NPPA, NPR1, CYC1 | KMT2A 4574/4885MEN1 469/4885MGLL 4597/4885 |
| US-20260014248-A1 | MRNA FOR SARS-COV-2 S PROTEIN AND USE THEREOF | SARS1, HNRNPA2B1, TRIM28 | KMT2A 3360/4885MEN1 2675/4885MGLL 2841/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.